Advancements in Alzheimer’s disease The New Age of Alzheimer’s (Links to an external site) Scientific American April 18, 2024 Podcast: Newly approved drug may slow progression of Alzheimer’s (Links to an external site) WashU School of Medicine news release August 4, 2023 Lilly drug slows Alzheimer’s by 35%, bolstering treatment approach (Links to an external site) Reuters – May 8, 2023 May 8, 2023 Conquering Alzheimer’s: a look at the therapies of the future (Links to an external site) Nature – Apr 4, 2023 April 7, 2023 Focused ultrasound technique leads to release of neurodegenerative disorders biomarkers (Links to an external site) The Source, Washington University in St. Louis – Feb 3, 2023 February 3, 2023 FDA APPROVES LEQEMBI™ (LECANEMAB-IRMB) UNDER THE ACCELERATED APPROVAL PATHWAY FOR THE TREATMENT OF ALZHEIMER’S DISEASE (Links to an external site) Eisai Co., Ltd. – Jan 06 2023 January 7, 2023 WashU, Eisai form drug discovery collaboration (Links to an external site) The Source, Washington University in St. Louis – Dec 14, 2022 December 16, 2022 [Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on Phase III GRADUATE programme evaluating gantenerumab in early Alzheimer’s disease (Links to an external site) Roche – Nov 14, 2022 November 15, 2022 LECANEMAB CONFIRMATORY PHASE 3 CLARITY AD STUDY MET PRIMARY ENDPOINT, SHOWING HIGHLY STATISTICALLY SIGNIFICANT REDUCTION OF CLINICAL DECLINE IN LARGE GLOBAL CLINICAL STUDY OF 1,795 PARTICIPANTS WITH EARLY ALZHEIMER’S DISEASE (Links to an external site) Eisai Co., Ltd. – Sept 27 2022 September 28, 2022 Roche provides update on Alzheimer’s Prevention Initiative study evaluating crenezumab in autosomal dominant Alzheimer’s disease (Links to an external site) F. Hoffmann-La Roche Ltd – June 16, 2022 June 16, 2022 Blood test for Alzheimer’s highly accurate in large, international study (Links to an external site) The Source, Washington University in St. Louis – Feb 22, 2022 February 23, 2022 Dementia First blood test to help diagnose Alzheimer’s goes on sale (Links to an external site) AP News – November 30, 2020 December 7, 2020 Why Didn’t She Get Alzheimer’s? The Answer Could Hold a Key to Fighting the Disease (Links to an external site) New York Times – Nov 4 2019 November 4, 2019 ‘Reports of My Death Are Greatly Exaggerated.’ Signed, Aducanumab (Links to an external site) Alzforum – Oct 24 2019 October 24, 2019 The importance of prevention trials in Alzheimer’s disease with Randall Bateman (Links to an external site) Neuro Central, September 23, 2019 September 25, 2019 Blood test is highly accurate at identifying Alzheimer’s before symptoms arise (Links to an external site) Washington University School of Medicine, August 2, 2019 August 9, 2019
Podcast: Newly approved drug may slow progression of Alzheimer’s (Links to an external site) WashU School of Medicine news release August 4, 2023
Lilly drug slows Alzheimer’s by 35%, bolstering treatment approach (Links to an external site) Reuters – May 8, 2023 May 8, 2023
Conquering Alzheimer’s: a look at the therapies of the future (Links to an external site) Nature – Apr 4, 2023 April 7, 2023
Focused ultrasound technique leads to release of neurodegenerative disorders biomarkers (Links to an external site) The Source, Washington University in St. Louis – Feb 3, 2023 February 3, 2023
FDA APPROVES LEQEMBI™ (LECANEMAB-IRMB) UNDER THE ACCELERATED APPROVAL PATHWAY FOR THE TREATMENT OF ALZHEIMER’S DISEASE (Links to an external site) Eisai Co., Ltd. – Jan 06 2023 January 7, 2023
WashU, Eisai form drug discovery collaboration (Links to an external site) The Source, Washington University in St. Louis – Dec 14, 2022 December 16, 2022
[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on Phase III GRADUATE programme evaluating gantenerumab in early Alzheimer’s disease (Links to an external site) Roche – Nov 14, 2022 November 15, 2022
LECANEMAB CONFIRMATORY PHASE 3 CLARITY AD STUDY MET PRIMARY ENDPOINT, SHOWING HIGHLY STATISTICALLY SIGNIFICANT REDUCTION OF CLINICAL DECLINE IN LARGE GLOBAL CLINICAL STUDY OF 1,795 PARTICIPANTS WITH EARLY ALZHEIMER’S DISEASE (Links to an external site) Eisai Co., Ltd. – Sept 27 2022 September 28, 2022
Roche provides update on Alzheimer’s Prevention Initiative study evaluating crenezumab in autosomal dominant Alzheimer’s disease (Links to an external site) F. Hoffmann-La Roche Ltd – June 16, 2022 June 16, 2022
Blood test for Alzheimer’s highly accurate in large, international study (Links to an external site) The Source, Washington University in St. Louis – Feb 22, 2022 February 23, 2022
Dementia First blood test to help diagnose Alzheimer’s goes on sale (Links to an external site) AP News – November 30, 2020 December 7, 2020
Why Didn’t She Get Alzheimer’s? The Answer Could Hold a Key to Fighting the Disease (Links to an external site) New York Times – Nov 4 2019 November 4, 2019
‘Reports of My Death Are Greatly Exaggerated.’ Signed, Aducanumab (Links to an external site) Alzforum – Oct 24 2019 October 24, 2019
The importance of prevention trials in Alzheimer’s disease with Randall Bateman (Links to an external site) Neuro Central, September 23, 2019 September 25, 2019
Blood test is highly accurate at identifying Alzheimer’s before symptoms arise (Links to an external site) Washington University School of Medicine, August 2, 2019 August 9, 2019